Impact of antibiotics on survival outcomes and risk of gastritis/colitis in advanced-stage melanoma patients receiving immune checkpoint inhibitor therapy
Antibiotic timing and spectrum of activity may be predictive of survival outcomes and risk of developing gastritis/colitis in ICI-treated patients with advanced-stage melanoma. Unlike previous studies, we found improved survival in patients receiving antibiotics during treatment and in those receiving antibiotics without anaerobic coverage.
Authors
- Bailey Sj
- T. Vincent
- Yusuf M. Mohamoud
- Vincent Pozorski (ORCID: https://orcid.org/0000-0002-4597-0794)
- Elizabeth N Dow-Hillgartner
- Lindsey Jung (ORCID: https://orcid.org/0000-0003-1460-7463)
- Thomas C. Havighurst (ORCID: https://orcid.org/0000-0002-9270-3189)
- Alexander Birbrair
- Janmesh D. Patel
- Dahlia Tesfamichae
Institutions
- University of Iowa (US)
- University of Wisconsin–Madison (US)
- UW Health University Hospital (US)
Publication Details
- Journal
- Immunotherapy
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/1750743x.2026.2626241
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Wisconsin-Madison
- University of Wisconsin Carbone Cancer Center
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- National Center for Advancing Translational Sciences